Gene Query: PAK6

Dataset Description Geneva Score
EP400 is required for Max and MCPyV mediated gene activation 49.71
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 27.88
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 23.78
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 15.39
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 14.08
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 13.47
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 10.9
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 10.9
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.88
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.88
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 9.71
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 9.13
IRF2 is a master regulator of human keratinocyte stem cell fate 9.13
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 8.75
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 8.39
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 8.33
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 8.18
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.0
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.0
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 7.95
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 7.8
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 7.14
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.07
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 7.01
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 6.39
SUV420H2 knockdown in PANC-1 6.17
BAF controls genome accessibility 5.82
Transcriptome analysis of virus infected tissues 5.81
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 5.46
MCF10A H-Ras RNA-Seq 5.35
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.07
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 5.01
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 4.82
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 4.82
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.77
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.76
Identification of renal resident macrophages across species [C1] 4.7
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 4.68
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 4.54
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 4.48
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 4.42
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 4.41
Primary human trophoblast from term placenta 4.28
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 4.26
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 3.87
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 3.83
Effect of Hotair overexpression in human breast cancer cell lines 3.73
Generation of KRAS signatures using immortalized isogenic lung cells. 3.66
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 3.65
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.63
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.63
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.62
PRDM1 inhibits proliferation of human colon cancer organoids 3.57
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.56
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.53
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 3.51
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 3.51
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.49
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 3.47
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 3.42
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 3.41
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 3.39
Global epigenomic reconfiguration during mammalian brain development 3.34
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 3.28
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 3.28
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 3.27
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.25
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 3.19
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.16
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.12
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 3.04
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 3.04
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 3.04
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 3.03
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 3.02
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.01
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 3.0
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.0
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.98
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 2.98
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.96
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.96
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 2.94
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.92
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 2.92
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.91
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.91
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.87
Identification of renal resident macrophages across species 2.87
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 2.86
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.83
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 2.77
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 2.76
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 2.74
RNA-seq of human aneuploid cell lines with Trisomy 21 2.74
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.64
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 2.61
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 2.59
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.56
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 2.55
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 2.53
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 2.52
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.5
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.49
Expression profiles of the four human major ectodermal lineages 2.49
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 2.47
Examining serotonergic neuron differentiation from human iPSCs 2.45
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 2.42
The Glioma-Infiltrating T Cell Receptor Repertoire 2.39
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 2.38
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.37
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 2.36
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.35
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.35
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.35
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.35
RNA-Seq of the corpus callosum from 12 individuals 2.33
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 2.31
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 2.3
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.29
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 2.29
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 2.29
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 2.23
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 2.23
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 2.22
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.2
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 2.2
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.16
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.16
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.15
Differential gene expression profiles in imatinib-resistant cell lines 2.14
WRN knockout effects upon gene expression in SW48 and OVK18 2.11
Repurposing of promoters and enhancers during mammalian evolution 2.08
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.08
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 2.02
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 2.02
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 2.02
Transcriptional responses of human insulinoma cells to acute cytokine exposure 2.02
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.01
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 1.96
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 1.96
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.95
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.92
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.92
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 1.9
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 1.89
A prostate cancer chromatin interaction map 1.88
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.87
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.86
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 1.84
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 1.82
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.81
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.8
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.8
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.77
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.74
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.73
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.73
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.7
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 1.7
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 1.68
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 1.67
CSL RNA-Seq on HKC and SCC cell lines 1.67
CSL 1.67
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.66
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.66
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 1.65
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.63
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.61
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.61
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.61
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.61
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 1.55
Epigenome regulation during epidermal lineage commitment 1.55
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 1.54
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 1.54
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.53
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 1.53
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 1.52
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 1.51
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 1.49
The Human Testis Cell Atlas via Single-cell RNA-seq 1.49
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.47
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.47
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.46
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 1.45
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 1.45
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.45
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.44
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 1.44
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.43
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.43
Pharmacologic inhibition of STAT5 in AML 1.42
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.41
Disruption of GRIN2B impairs differentiation in human neurons 1.41
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.4
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.4
The Genomic Landscape of Atypical Fibroxanthoma 1.4
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 1.39
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 1.39
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 1.39
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 1.39
Effect of nuclear IL-33 on gene expression 1.39
Human HAP1 cells before and after nutrient deprivation 1.39
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 1.39
SNHG5 siRNA knock down in HCT116 cells 1.39
RNA-seq analyses of human prostate cancer cells 1.37
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 1.37
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 1.36
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.35
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.34
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 1.33
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.33
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.33
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.33
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 1.32
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 1.32
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.32
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 1.31
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 1.31
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 1.3
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 1.3
Discovering human diabetes-risk gene function with genetics and physiological assays 1.29
Fbxo32 mediated gene expression program underlies EMT and metastasis 1.29
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 1.28
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 1.28
Knockdown of ADNP in HCT116 colon cancer cells 1.27
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.27
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.27
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.25
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 1.25
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 1.25
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.24
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 1.23
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.23
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 1.23
Neonatal and adult human testis defined at the single-cell level 1.21
RNA-seq of cancer cell lines treated with T-025 1.19
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.19
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.19
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 1.17
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.16
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 1.16
The landscape of alternative splicing in aggressive prostate cancers 1.15
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 1.14
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.14
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.14
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.13
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.13
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 1.12
circRNA-sequencing 1.1
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 1.1
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 1.1
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 1.1
Universal alternative splicing of noncoding exons 1.09
Ectoderm specification of H1 human embryonic stem cells 1.08
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.07
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.07
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 1.07
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.06
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.06
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.05
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 1.05
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 1.05
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.03
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.03
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.03
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.03
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.03
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 1.03
The conserved transcriptional landscapes in human spermatogenesis 1.03
RNA-seq of MCF10A cells and CAF 1.02
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.02
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.02
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.02
Depicting early human development and germ cell origin with porcine embryos 1.01
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.01
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 1.01
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 1.0
Lipid degradation promotes prostate cancer cell survival 1.0
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.0
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.99
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.99
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.99
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 0.99
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 0.99
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.99
RNA-seq of YB5 cells treated with Proscillaridin A 0.99
Microglia innatly develop within cerebral organoids 0.98
RNAseq of IL-36 stimulated primary human keratinocytes 0.98
Gene expression changes caused by KRAS in MCF-10A 0.98
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.97
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.97
Transcriptome profiling of Normal and Cancerous Prostate Cells 0.97
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 0.97
Splicing and epigenetic factors jointly regulate epidermal differentiation 0.96
Global transcriptome analysis of HAP1 cells 0.96
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.96
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.96
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.96
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.95
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 0.95
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.95
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.95
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 0.94
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 0.94
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.94
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 0.92
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.91
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.91
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.91
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.91
NKX2.2 0.91
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 0.91
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 0.91
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.89
Gene Expression Profiling of SPOP Knocked Down Cell 0.88
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.88
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.88
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.86
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.85
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 0.84
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.84
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 0.84
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 0.84
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.83
RNA-sequencing in immortalized human mammary epithelial cells 0.83
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 0.83
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.83
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.83
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.82
LncRNA-GAS5 negative regulation of YAP-target genes expression 0.82
Activity-dependent transcriptional changes in human neurons 0.82
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.81
Rorc disruption in human FG pancreatic cancer cells 0.8
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 0.79
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.77
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.77
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 0.77
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.77
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.74
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.74
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.74
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.73
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.73
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.73
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.73
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.72
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.71
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.7
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.67
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.66
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.65
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.63
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.63
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.63
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.63
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.63
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.62
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.62
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.61
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.61
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.6
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 0.6
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.59
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.59
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.59
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.58
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 0.58
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.57
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.57
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 0.57
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.57
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.57
Identification of long noncoding RNAs regulated by p53 0.56
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.55
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.55
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.54
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.54
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 0.53
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 0.53
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 0.53
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.53
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.52
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 0.5
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.5
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.5
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.5
Transcriptome analyses of human pancreatic islets and pseudoislets 0.5
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 0.5
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.48
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.48
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.48
Investigate A2M treatment on human prostate cancer and mouse liver 0.47
Investigate A2M treatment on human prostate cancer xenograft in mice 0.47
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.47
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.46
The role of CFTR in islet function 0.45
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 0.44
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.44
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 0.43
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.43
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.43
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.42
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.42
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.41
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.41
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.41
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.39
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.39
RNA-seq of naive and primed ES cells 0.39
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.39
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.38
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.37
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.36
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.36
Transcriptomic analysis of frontal fibrosing alopecia 0.35
Molecular Criteria for Defining the Naive Human Pluripotent State 0.35
Leucegene: ALL sequencing 0.35
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.34
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.34
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.34
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.34
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.33
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.33
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 0.33
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.32
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 0.31
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 0.31
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.31
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.31
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.31
Single cell transcriptome of peritoneal cells 0.3
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.29
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.29
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.29
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.28
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.28
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 0.27
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.26
Expression profiling of converted and control dermal BJ fibroblasts 0.26
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 0.26
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.25
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.24
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.23
CDK4/6 inhibitor resistance in prostate cancer 0.23
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.23
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.21
Downregulation of LATS kinases alters p53 to promote cell migration 0.21
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.2
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.2
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.2
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.2
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.19
mRNA sequencing of oropharyngeal cancer cell lines 0.18
RNAseq in Alzheimer's Disease patients 0.17
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.16
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.16
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.16
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.15
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.15
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.15
Human islets of varying quality: the good, the (not so) bad and the ugly 0.15
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.15
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.14
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.14
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.14
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.14
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.14
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.14
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.14
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.13
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.13
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.13
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.13
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.12
The circadian transcriptional landscape in primary human mammary epithelial cells 0.12
RNA sequencing of human pancreatic cancer cell lines 0.12
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.12
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.11
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.1
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.09
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 0.09
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.09
STX4 Over-Expression in Human islets 0.08
RNA-Seq in PWS iPSC-derived neurons 0.07
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.07
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.07
H1609088 Human RNA-Sequencing 0.07
The cohesin release factor WAPL restricts chromatin loop extension. 0.07
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.07
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.06
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.06
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.04
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.04
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.02
Preclinical model of obesity and ER-positive breast cancer 0.0
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation